LON:NCYT

Novacyt (NCYT) Share Price, News & Analysis

Novacyt logo
GBX 36.08 -0.33 (-0.89%)
As of 04:03 AM Eastern

About Novacyt Stock (LON:NCYT)

Advanced

Key Stats

Today's Range
35.90
▼
36.08
50-Day Range
34.40
▼
44
52-Week Range
26.60
▼
86
Volume
3,880 shs
Average Volume
160,377 shs
Market Capitalization
£26.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine. The Company develops, manufactures, and commercialises a range of molecular assays and instrumentation to deliver workflows and services that enable seamless end-to-end solutions from sample to result across multiple sectors including human health, animal health and environmental. The Company is divided into three business segments: Clinical Broad portfolio of human clinical in vitro diagnostic products, workflows and services focused on three therapeutic areas: · Reproductive Health: NIPT, Cystic Fibrosis and other rapid aneuploidy tests · Precision Medicine: DPYD genotyping assay · Infectious Diseases: Winterplex, multiplex winter respiratory PCR panel Instrumentation Portfolio of next generation size selection DNA sample preparation platforms and rapid PCR machines, including: · Ranger® Technology: automated DNA sample preparation and target enrichment technology MyGo: real-time quantitative PCR (qPCR) instruments Research Use Only Range of services for the life sciences industry: · Design, manufacture, and supply of high-performance qPCR assays and workflows for use in human health, agriculture, veterinary and environmental, to support global health organisations and the research industry · Pharmaceutical research services: whole genome sequencing (WGS) / whole exome sequencing (WES) Novacyt is headquartered in Vélizy-Villacoublay in France with offices in the UK (in Stokesley, Eastleigh and Manchester), Taipei, Singapore, the US and Canada and has a commercial presence in over 65 countries. The Company is listed on the London Stock Exchange's AIM market ("NCYT") and on the Paris Stock Exchange Euronext Growth ("ALNOV"). For more information, please refer to the website: www.novacyt.com

Receive NCYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novacyt and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NCYT Stock News Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Headlines

NCYT Stock Analysis - Frequently Asked Questions

Novacyt's stock was trading at GBX 35.90 at the beginning of 2026. Since then, NCYT stock has increased by 2.8% and is now trading at GBX 36.90.

Novacyt S.A. (LON:NCYT) issued its earnings results on Wednesday, September, 30th. The company reported GBX (8) earnings per share for the quarter. Novacyt had a negative trailing twelve-month return on equity of 159.13% and a negative net margin of 102.66%.

Shares of NCYT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novacyt investors own include boohoo group (BOO), Lloyds Banking Group (LLOY), LoopUp Group (LOOP), Petropavlovsk (POG), Rolls-Royce Holdings plc (RR.L), Saga (SAGA) and BP (BP).

Company Calendar

Last Earnings
9/30/2026
Today
11/18/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
LON:NCYT
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£36.80 million
Net Margins
-102.66%
Pretax Margin
N/A
Return on Equity
-159.13%
Return on Assets
-27.98%

Debt

Debt-to-Equity Ratio
54.74
Current Ratio
3.14
Quick Ratio
4.46

Sales & Book Value

Annual Sales
£21.79 million
Price / Sales
1.19
Cash Flow
GBX 61.85 per share
Price / Cash Flow
0.58
Book Value
GBX 99.62 per share
Price / Book
0.36

Miscellaneous

Outstanding Shares
72,523,000
Free Float
N/A
Market Cap
£26.04 million
Optionable
Not Optionable
Beta
1.11
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (LON:NCYT) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners